Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Brave Bioscience AB
AB
Active
Org 5592696651
Linnégatan 10 D, 224 60
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2020 · 5 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Brave Bioscience AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: 1M
1M
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: 1M
1M
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
318
1 243
819
127
1 131
Staff expenses
—
−0
−1
−1
—
EBITDA
−79
326
512
−71
595
Depreciation & amort.
—
—
—
—
−0
EBIT
−79
326
512
−71
595
Net financials
4
8
4
1
—
Profit before tax
−5
250
387
−3
450
Tax
—
−52
−80
—
−94
Net profit
−5
197
306
−3
356
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
804
1 223
909
579
947
Equity
520
526
328
22
381
Long-term debt
—
—
—
—
0
Short-term debt
60
404
372
478
420
Total debt
60
404
372
478
420
Financial ratios
5-year trend
EBITDA margin
−25,0 %
This company
15,8 %
Market median
This company
Market median
258% below market
2021
2025
Equity ratio
64,8 %
This company
38,2 %
Market median
This company
Market median
70% above market
2021
2025
Return on equity
−1,0 %
This company
18,4 %
Market median
This company
Market median
105% below market
2021
2025
Net profit margin
−1,7 %
This company
8,1 %
Market median
This company
Market median
121% below market
2021
2025
Asset turnover
0,40×
This company
1,12×
Market median
This company
Market median
64% below market
2021
2025
Debt / equity
0,54×
This company
0,62×
Market median
This company
Market median
13% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
View
PDF
More on Brave Bioscience AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
